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Abstract
Background: Obtaining informed consent for clinical trials is especially challenging when working in rural, resource-limited
areas, where there are often high levels of illiteracy and lack of experience with clinical research. Such an area, a remote field
site in the northeastern part of the state of Minas Gerais, Brazil, is currently being prepared for clinical trials of experimental
hookworm vaccines. This study was conducted to assess whether special educational tools can be developed to increase
the knowledge and comprehension of potential clinical trial participants and thereby enable them to make truly informed
decisions to participate in such research.
Methodology/Principal Findings: An informational video was produced to explain the work of the research team and the
first planned hookworm vaccine trial, using a pedagogical method based on analogies. Seventy-two adults living in a rural
community of Minas Gerais were administered a structured questionnaire that assessed their knowledge of hookworm, of
research and of the planned hookworm vaccine trial, as well as their attitudes and perceptions about the researchers and
participation in future vaccine trials. The questionnaire was administered before being shown the educational video and
two months after and the results compared. After viewing the video, significant improvements in knowledge related to
hookworm infection and its health impact were observed: using a composite score combining related questions for which
correct answers were assigned a value of 1 and incorrect answers a value of 0, participants had a mean score of 0.76 post-
video compared to 0.68 pre-video (p=0.0001). Similar improvements were seen in understanding the purpose of
vaccination and the possible adverse effects of an experimental vaccine. Although 100% of participants expressed a positive
opinion of the researchers even before viewing the film and over 90% said that they would participate in a hookworm
vaccine trial, an increase in the number who expressed fear of being vaccinated with a novel vaccine was seen after viewing
the video (51.4% post-video versus 29.2% pre-video). Increases were also seen in the proportion who thought that
participation in a vaccine trial would be inconvenient or disrupt their daily activities.
Conclusions/Significance: Even in rural, resource-limited populations, educational tools can be specially designed that
significantly improve understanding and therefore the likelihood of obtaining truly informed consent for participation in
clinical research. The observed changes in the knowledge and perceptions of the research participants about hookworm
infection and the experimental hookworm vaccine demonstrate that the video intervention was successful in increasing
understanding and that the subjects acquired knowledge pertinent to the planned research.
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Introduction
In research involving human subjects, the ethical relationship
that must be established and maintained between investigators and
research subjects is essential to successfully conduct investigational
clinical trials of experimental drugs or vaccines, especially ones in
which the participants aredrawn from vulnerable populations [1,2].
In such studies, investigators must attempt to mitigate any possible
manipulation of the research population during the recruitment
process, and especially to ensure that the risks and benefits to which
volunteers are going to be exposed are well understood [3,4]. The
informed consent document is the traditional instrument utilized for
this aim; by signing it, it is assumed that the volunteer has freely
exercised their will, has formed their own evaluation and critique of
the proposed research and has arrived at a truly informed decision
about participation [5–8].
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challenging when working in rural, resource-limited settings.
Although there is no consensual definition of vulnerability, age,
socioeconomic status, access to basic services such as health and
sanitation, ethnic group, religion, cultural affiliation, and educa-
tional level are all characteristics that have been cited as indicating
vulnerability, and which may therefore influence an individual’s
ability to consent to participation in clinical trials both in terms of
the ability to exercise autonomy, but also to comprehend the
proposed research [3,9,10]. With respect to the latter challenge, the
informed consent form must frequently convey complex technical
information and scientific concepts that are often not easily
understandable, especially in populations with low levels of literacy
[11–13]. To improve the quality of the information transmitted to
potential study participants, researchers have, in general, increased
the amount of information in informed consent documents [11].
However, a document that contains extensive and complex
information may not convey a satisfactory understanding of the
study procedures, or of the potential risks and benefits of
participation in the research [14]. As an example, after evaluating
the understanding of the information in an informed consent
document for a research project in San Francisco, California,
researchers found that despite using a form that had been simplified
using language appropriate for a primary school level, the majority
of individuals required more than one explanation of the study
before satisfactorily comprehending it [12]. In that study, low
literacy level and socioeconomic status were associated with an
increased need for interventions that gave an improved compre-
hension of the information contained in the document.
In addition to the issue of comprehension, recruiting volunteers
into clinical trials being conducted in resource-limited settings is
further complicated by the limited access to medical care that is
frequently found in such areas. Frequently, potential research
subjects may feel an obligation to participate in order to receive
medical attention for themselves or their family members [15].
Such motivation could influence individuals to participate and
undertake risks that they otherwise would not accept.
Despite these very real issues related to obtaining informed
consent from vulnerable populations living in resource-limited
settings, it is often necessary to conduct clinical trials in such areas,
particularly when the product being developed is meant to treat or
prevent a disease that affects such a population. As one example,
hookworm infection is one of the most prevalent chronic infections
of humans, with an estimated 740 million cases worldwide, mostly
in rural poor rural areas of the tropics and subtropics [16]. The
two hookworms that infect humans are Necator americanus and
Ancylostoma duodenale, with infection being transmitted through skin
contact with soil contaminated with infective larvae. The major
clinical manifestations result primarily from the loss of blood
caused by adult worms that attach onto the intestinal wall,
resulting in anemia which subsequently can lead to delays in
cognitive development in children and reduction of well-being and
productivity in adults [17].
Although effective chemotherapy exists to treat hookworm,
current anthelminthics have important limitations, not least of
which is that re-infection often occurs within a short time after
treatment due to ongoing exposure [18,19]. To develop an
alternative control tool, the Human Hookworm Vaccine Initiative
(HHVI) is developing a vaccine to prevent the morbidity due to
this parasitic infection. Since hookworm does not occur in the
developed world, testing the safety and efficacy of vaccines
targeting this parasite must be conducted in the rural, resource-
limited areas where the disease is endemic, among populations
which are frequently referred to as being ‘‘vulnerable.’’
The HHVI has been preparing a trial site for studies of its
investigational hookworm vaccines that is based in the town of
Americaninhas, in the northeast part of the Brazilian state of
Minas Gerais [20,21]. The first experimental vaccine being
developed by the HHVI – the Na-ASP-2 Hookworm Vaccine –
was tested there in a phase 1 clinical trial in 2007. For this study,
healthy adult volunteers were recruited from communities
surrounding Americaninhas.
In advance of this trial, studies were performed to assess the
baseline knowledge of potential study participants in order to
design appropriate educational interventions that could be used in
the consenting process. Unfortunately, little is known about which
are the more appropriate pedagogic models for informing
populations involved in clinical trials, especially vulnerable
populations that are economically or educationally disadvantaged.
In the field of health education, purely informative pedagogic
models do not usually result in modification of positions or
attitudes, since behaviors are manifestations of firmly-held values
and beliefs [22]. The ideal nature of an educational intervention
that leads to acquisition of the knowledge necessary to make a
conscious decision about participating in a research study is a
matter of debate. Several authors have proposed a pedagogic
model that makes use of the analogy [11,23]. Analogies are useful
tools for forming mental constructs that simplify or render familiar
what an individual is attempting to understand [24]. The use of
analogies can introduce new scientific concepts or alter previously
held ideas [25], and can overcome barriers to learning by allowing
an individual to make creative connections between pre-existing
concepts and those related to the new knowledge being presented
[23]. With this in mind, the current study aimed to develop an
educational intervention based on analogies for a population
resident in a hookworm endemic area of Brazil, and to evaluate its
effectiveness in disseminating knowledge about the disease caused
by hookworm, the experimental Na-ASP-2 vaccine that was about
to be tested in their community, and about attitudes related to
their willingness to participate in clinical trials of the vaccine.
Author Summary
Conducting clinical trials of new vaccines in rural, resource-
limited areas can be challenging since the people living in
these areas often have high levels of illiteracy, little
experience with clinical research, and limited access to
routine health care. Especially difficult is obtaining
informed consent for participation in this type of research
and ensuring that potential participants adequately
understand the potential risks and benefits of participa-
tion. The researchers have been preparing a remote field
site in the northeastern part of the state of Minas Gerais,
Brazil, for clinical trials of experimental hookworm
vaccines. A special educational video was designed based
on the method of analogies to introduce new scientific
concepts related to the researchers’ work and to improve
knowledge of hookworm, a disease that is highly prevalent
in their community. A questionnaire was administered
both before and after the video was shown to a group of
adults at the field site, which demonstrated the effective-
ness of the video in disseminating knowledge about
hookworm infection and about the vaccine being devel-
oped. Therefore, even in a rural, resource-limited area,
educational tools can be specially designed that signifi-
cantly improve understanding and therefore the likelihood
of obtaining truly informed consent for participation in
clinical research.
Preparation for Hookworm Vaccine Trials in Brazil
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This research was conducted as part of a larger epidemiological
study whose purpose was to establish the prevalence of hookworm
infection in various communities in the study area, in advance of
planned hookworm vaccine trials.
Study Site
The study was conducted in 2007 in the communities of
Furtado, Beija-Flor and Jamir, all of which are rural areas endemic
for hookworm located in the region surrounding the town of
Americaninhas in the municipality of Novo Oriente de Minas, 500
kilometers northeast of Belo Horizonte, the capital of the Brazilian
state of Minas Gerais. Americaninhas is located in a mountainous
region with a tropical climate [20,26]. The population largely
exists on subsistence farming of cassava, sugar cane, coffee and
beans. They typically live in simple, hand-made dwellings of
packed earth or adobe with roofs of corrugated iron.
The population of Americaninhas consists of around 1000
people living in the urban center, with another 4000 living in the
surrounding rural areas in smaller hamlets. Approximately 500
people live in the communities of Furtado, Beija-Flor and Jamir.
This region was chosen for conducting clinical trials of
experimental hookworm vaccines in view of the elevated
prevalences of helminth infections that have been found during
previous studies performed by the research team in the area: 68%
for the hookworm N. americanus, 45% for Schistosoma mansoni, and
49% for Ascaris lumbricoides [20]. Such high prevalences are the
result of socioeconomic and environmental conditions that favor
the transmission and development of hookworm, such as a warm
and humid climate, a lack of basic sanitation, and the low
socioeconomic status of the population.
Study Population
Individuals were included in the study if they were between the
ages of 16 and 50 years and had been resident in the study area for
the previous 24 months; were infected with hookworm as
determined during the course of the larger epidemiological study;
and, had completed a course of treatment for hookworm with
albendazole. All volunteers consented to participate in the
research, as evidenced by their signature on the informed consent
form approved by the ethical review committees of the Centro de
Pesquisas Rene Rachou (part of the Fundac ¸a ˜o Oswaldo Cruz –
FIOCRUZ) and the George Washington University Medical
Center, and completion of a true/false questionnaire that assessed
their understanding of the informed consent document. Volun-
teers had to respond correctly to all questionnaire questions prior
to being considered for inclusion into the study. In the cases of
volunteers unable to read, the consent form was read aloud to
them in the presence of an independent witness who also signed
the form after the volunteer affixed their thumbprint.
Educational Intervention
The intervention was an educational video containing details
about the proposed Na-ASP-2 vaccine trial, as well as explanations
regarding the nature of research, the work of researchers, the
reasons the area was chosen to test a vaccine against hookworm,
and concepts of hookworm disease, vaccination, and the use of
placebos in vaccine trials (Videos S1, S2, S3, S4, S5, S6, S7, S8,
and S9). The video was filmed in the communities of Jamir and
Beija Flor, and was produced using a pedagogical approach based
on the use of analogies. In it, the daily experiences of local
inhabitants, such as the cultivation of cassava, and the making of
flour, sweets and cheese, are compared to the manufacturing of
vaccines and to the experiments of researchers working in the
laboratory. The characters featured in the film are actual
inhabitants of the community who are representative of those
from the rural interior of the state of Minas Gerais, thus facilitating
identification of the viewer with the individuals on screen and
enabling the learning process.
The film opens with scenes showing typical day in the town of
Americaninhas, with people enjoying themselves in the town
square or observing the main street from their windows (Video
S1). After these initial images, the film transitions to describing the
production of a traditional regional sweet. Each step in its
production is shown, starting with cultivation of the sugar cane
from which the basic ingredient is derived, followed by extraction
of cane juice using a machine, preparation of the other ingredients,
and combining these in specific quantities to create a final, high-
quality product. Interspersed with these images are those of
FIOCRUZ researchers working in the laboratory, using machines
and instruments to assist them in discovering ideal components
that, when combined in the correct amounts, may produce an
effective vaccine. An analogy is thereby constructed between
typical experiences of the region such as the production of sweets
and the manufacturing of a vaccine against hookworm.
The video then shows people being interviewed about their
knowledge of hookworm using language that is unique to the local
population (Videos S2, S3, and S4). The individuals discuss the
illness known locally as ‘‘amarela ˜o’’ or the ‘‘illness of Jeca-tatu’’
(after a popular cartoon character from the early 20
th century), its
mode of transmission, and the associated symptoms. Their
perceptions of the researchers working in the area and what
they’re doing in the region, as well as the hookworm vaccine
program and the possible adverse effects of such a vaccine, are also
presented.
In the final part of the video, members of the HHVI team speak
on camera about the hookworm vaccine project, to clarify details
of the planned clinical trial (Videos S5, S6, S7, S8, and S9). The
presenters explain why hookworm is endemic in their community,
the criteria for inclusion in the forthcoming vaccine trial, the
adverse effects that the vaccine might cause, as well as how the
vaccine is made.
The video was shown to prospective vaccine trial participants in
group sessions in their own communities. After presentation of the
film, conversation was encouraged to discuss and debate what was
viewed so that the presented knowledge could be consolidated and
learned.
Data Collection
Data were collected by means of a structured survey consisting
of 45 questions, which was designed to assess knowledge about
hookworm, vaccines (in general and the Na-ASP-2 vaccine in
particular), and the researchers, as well as attitudes related to their
willingness to participate in clinical trials of hookworm vaccines
(Text S1). The questionnaire consisted of a combination of true or
false questions, multiple choice questions, and subjective questions
answered according to the 5-point Likert scale (ranging from
‘‘strongly disagree’’ to ‘‘strongly agree’’). Survey questions were
divided into three categories: a) those assessing knowledge about
hookworm (Group 1); b) those assessing knowledge about the
hookworm vaccine and upcoming clinical trial (Group 2); and, c)
those assessing the attitudes and feelings of individuals about illness
due to hookworm, vaccines, and participation in vaccine trials
(Group 3).
The survey was first pilot tested on a group of 20 adults. After
conducting this pilot test, modifications were made to improve the
understanding of the tool by the general public. The survey was
Preparation for Hookworm Vaccine Trials in Brazil
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once immediately before viewing the educational video described
above and then approximately two months later.
Statistical Analysis
Data were tabulated and analyzed using the SPSS software
program (version 15). Of the 45 questions on the questionnaire,
only questions 2 through 40 were included in the analysis (the first
question was for informational purposes whereas the final three
concerned only those participants who had children). For
questions from Groups 1 and 2, the frequencies of each answer
were summarized. Responses to these questions were dichoto-
mized such that each correct answer was assigned a value of ‘‘1’’
and each incorrect answer a value of ‘‘0’’; a response of ‘‘don’t
know’’ was also assigned a value of ‘‘0’’ as it was considered a lack
of knowledge. Subsequently, the mean of the responses was
calculated for both the pre- and post-film administrations of the
questionnaire. Additionally, composite scores for knowledge about
hookworm and knowledge about the experimental hookworm
vaccine were obtained by calculating the mean of responses to
questions that fell into these broad categories. For the knowledge
about hookworm composite score, responses to 14 similar
questions were combined (#2–14, #26) whereas for knowledge
about the hookworm vaccine 6 questions (#15, #16, #18–20,
#30) were combined.
Questions in Group 3 were divided into two subgroups which
were analyzed using different methods: for the first subgroup,
answers were dichotomized such that an affirmative answer was
assigned a value of ‘‘1’’ and a negative answer a value of ‘‘0’’
whereas for the second subgroup, the Likert scale consisting of five
categories was used: 22 (strongly disagree), 21 (disagree), 0
(neither agree nor disagree), 1 (agree), and 2 (strongly agree). As for
the dichotomous responses, means were calculated for each Likert
scale question and compared pre- and post-film; to do this, the
‘‘strongly disagree’’ and ‘‘disagree’’ categories were combined and
assigned a value of ‘‘0’’, and the ‘‘strongly agree’’ and ‘‘agree’’
categories were assigned a value of ‘‘1’’. As for the first two groups
of questions, a composite score for the attitudes and feelings of
study participants was created by combining individual responses
to 7 different questions from the questionnaire (#21–23, #27–29,
#31).
Student’s paired t-test was used to compare pre-film and post-
film means for both individual questions and the composite scores
for Groups 1 and 2. The chi-square test was used to compare
proportions for questions with several possible responses. For all
tests, a p value less than 0.05 was considered significant.
Results
Individuals were randomly selected from a list of participants
who had been enrolled in a large epidemiological study and were
invited to participate in the educational intervention. The initial
sample consisted of 127 subjects; however, 55 of these did not
undergo the second survey administration after viewing the
educational video. The final study sample therefore consisted of
72 volunteers who were included in the data analysis. The average
age of these participants was 30.1 years (range, 17 to 46 years),
with 33 (45.8%) being female and 39 (54.2%) male.
Knowledge about Hookworm and the Hookworm
Vaccine
When assessed as a composite score, knowledge about hook-
worm improved significantly after viewing the informational video
from a mean score of 0.68 before the video to 0.76 after the video
(p,0.0001), demonstrating that significant understanding was
acquired by the participants through the targeted educational
intervention. When assessing knowledge about vaccines and the
proposed clinical trials of the experimental Na-ASP-2 Hookworm
Vaccine, a small improvement was also seen after viewing the
video, with the mean of correct answers on the post-video
questionnaire being significantly higher than the mean on the pre-
video test (0.58 vs. 0.65, p=0.03) (Table 1).
Table 2 describes in more detail the specific knowledge
acquired about hookworm after viewing the film. The illness,
recognized by the popular name ‘‘amarela ˜o’’ (‘‘the big yellow’’) by
88.9% of participants prior to viewing the film, was identified by
the more scientific name ‘‘ancilostomı ´deo’’ by 91.7% of the study
subjects after seeing the film (compared to only 79.2% before,
p=0.01). The mode of transmission of hookworm, which in Brazil
is sometimes confused with other worm infections such as A.
lumbricoides and S. mansoni, was already correctly identified as being
through contact of skin with contaminated soil by 95.8% of
subjects before the film, which increased to 100% after viewing the
video (p=0.08). However, the common misconception that
hookworm infections are acquired through contact with contam-
inated water and unwashed fruit or vegetables, was abandoned by
a quarter of the subjects participating in the research after viewing
the educational film (88.9% pre-film vs. 63.9% post-film,
p,0.001).
After the educational intervention, 79.2% of participants
recognized that individuals can be infected with hookworm burt
be asymptomatic, compared to 66.7% who held this view prior to
seeing the film (p=0.1). The acquisition of this knowledge may be
crucial because health surveillance is intimately associated with the
recognition of the gravity of the disease and the acknowledgement
that it can be a ‘‘silent’’ illness. When asked about the negative
health consequences associated with hookworm infection, even
before viewing the educational film, 90.3% of participants
correctly identified anemia as an important result of hookworm
infection, compared to 93.1% after the film (p=0.5).
Table 1. Impact of the educational video on knowledge about hookworm and the experimental hookworm vaccine.
Composite Scores Mean Difference (95% CI) P*
Pre-video Post-video
Knowledge about hookworm
1 0.68 0.76 0.09 (0.05–0.12) 0.0001
Knowledge about the hookworm vaccine
2 0.58 0.65 0.07 (0.01–0.13) 0.03
*Paired Student’s t-test comparing responses before and after viewing the educational video.
1Composite of questions #2–14 and #26 from questionnaire.
2Composite of questions #15, #16, #18–20 and #30 from questionnaire.
doi:10.1371/journal.pntd.0000749.t001
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intervention when assessing the level of subjects’ comprehension
about the impact of illness due to hookworm in their community.
Although even before viewing the video 84.7% of the population
believed that hookworm was an important illness in their
community, which increased slightly to 91.7% of participants
afterward (p=0.2), a significant change was seen in the more subtle
question that asked whether participants thought that hookworm is
not a serious illness because it can be easily treated: initially, 72.2%
responded in the affirmative to this question whereas after viewing
the educational film and hearing more about the long-term
consequences of asymptomatic infection, only 45.8% held this
viewpoint (p,0.001). Furthermore, after viewing the educational
video more people understood that despite the existence of effective
drug therapy for hookworm infection, there are major limitations
with this treatment due to the probability of becoming re-infected,
which in many cases can occur rapidly following treatment,
although this increase in knowledge wasn’t statistically significant
(30.6% pre-video vs. 38.9% post-video, p=0.2).
When evaluating the participants’ knowledge about vaccines in
general and the upcoming hookworm vaccine trial in particular,
improvements in understanding were acquired after viewing the
educational film (Table 3). Regarding the purpose of vaccination,
the participants’ knowledge before and after the educational
intervention is shown in Figure 1. Results from the pre-film
survey demonstrate that a majority of participants (56.9%)
believed that the purpose of a vaccine is to treat an established
illness. Although following the film, this association was still made
by almost half of responders (45.8%), a significant increase did
occur in those associating a vaccine with illness prevention (41.7%
post-video vs. 20.8% pre-video, p=0.005).
To assess knowledge about the possible adverse effects caused
by vaccination, participants were asked what they thought could
happen if an experimental vaccine were administered to them.
The potential side effects of vaccination that they chose are
presented in Figure 2. Among the responses, the possibility of
experiencing an allergic reaction upon being vaccinated, which
was recognized by none of the interviewed participants prior to
viewing the educational video, was cited frequently during the
post-film test (43.1%), as was the possibility of experiencing arm
redness (at the site of injection) following vaccination (15.3% post-
video compared to 1.4% before, p=0.003). Of note, the
educational intervention was associated with a significant reduc-
tion in the proportion of individuals who answered ‘‘other’’ (18.1%
post-film vs. 54.2% pre-film, p,0.001) and a non-significant
reduction in those who chose ‘‘don’t know’’ as their response to
this question (9.7% post-film vs. 18.1% pre-film, p=0.15).
Attitudes and Perceptions
The participants’ perceptions about the nature of the work
being done by the FIOCRUZ research team in the study area are
shown in Figure 3. The level of comprehension regarding the
work of the researchers underwent significant change following the
presentation of the interventional video. Although the concept that
the work of a researcher is to take care of people’s health and treat
disease remained the perception of 30.6% and 33.3% of the
interviewed subjects, respectively, compared to 36.1% and 31.9%
who listed these roles prior to viewing the film (p=0.5 and 0.9,
respectively), there was a significant increase in the proportion of
participants who listed the function of the researcher as consisting
of conducting studies on a new vaccine (27.8% post-film vs. 4.2%
pre-film, p,0.001).
Table 2. Participants’ responses to questions about hookworm infection, before and after the educational video intervention.
Responses (%) P*
Pre-video Post-video
Question Yes No Yes No
Have you heard about ‘‘amarela ˜o
1’’? 88.9 11.1 100 0.0 0.004
Have you heard about ‘‘ancilostomı ´deo
2’’? 79.2 20.8 91.7 8.3 0.01
Can you have worms but not feel anything? 66.7 33.3 79.2 20.8 0.1
Is it possible that you are infected with hookworm/or the worms of ‘‘amarela ˜o’’? 70.8 29.2 84.7 15.3 0.03
Do you get infected with hookworm/worms of ‘‘amarela ˜o’’ by walking
barefoot or coming into contact with dirt?
95.8 4.2 100 0.0 0.08
Do you get infected with hookworm/worms of ‘‘amarela ˜o’’ by eating
unwashed fruits and vegetables or by drinking water?
88.9 11.1 63.9 36.1 ,0.001
Does hookworm/‘‘amarela ˜o’’ cause anemia? 90.3 9.7 93.1 6.9 0.5
Does only hookworm/‘‘amarela ˜o’’ cause anemia? 38.9 61.1 33.3 66.7 0.4
Is hookworm a major health issue in your community? 84.7 15.3 91.7 8.3 0.2
Hookworm is not a serious illness because it can be easily treated. 72.2 27.8 45.8 54.2 ,0.001
Hookworm can be treated with medications and once cured you can
never get it again.
69.4 30.6 61.1 38.9 0.2
Hookworm can be eliminated from your community if hygienic
practices are changed.
88.9 11.1 70.8 29.2 0.002
A fecal exam must be performed to know if you are infected with hookworm. 100 0.0 95.8 4.2 0.08
Infection with hookworm can cause serious long-term health problems. 91.7 8.3 84.7 15.3 0.1
*Paired Student’s t-test comparing responses before and after viewing the educational video.
1Brazilian Portuguese slang term for hookworm infection.
2Brazilian Portuguese term for the hookworm parasite.
doi:10.1371/journal.pntd.0000749.t002
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feelings of the participants towards the researchers and participa-
tion in a hookworm vaccine trial, there was no significant change
in the composite mean of responses before compared to after
viewing the film (0.86 vs. 0.83, p=0.07) (Table 4). Similarly, no
significant difference was found between the attitudes and feelings
Table 3. Participants’ responses to questions about hookworm infection, before and after the educational video intervention.
Responses (%) P*
Pre-video Post-video
Question Yes No Yes No
Do you know that people are testing a vaccine against hookworm? 63.9 36.1 95.8 4.2 ,0.001
Do you know what a vaccine does? 20.8 79.2 41.7 58.3 0.005
Will the expected results for a hookworm vaccine will be the same for everyone? 47.2 52.8 18.1 81.9 ,0.001
If you are vaccinated, could you experience red and sore arms, headache,
stomach ache, allergic reaction, death, or another reaction?
81.9 18.1 90.3 9.7 0.2
Will participants in the future hookworm vaccine study receive two
different types of vaccine?
41.7 58.3 75.0 25.0 ,0.001
Can only people who are sick participate in a vaccine study? 31.9 68.1 47.2 52.8 0.06
*Paired Student’s titest comparing responses before and after viewing the educational video.
doi:10.1371/journal.pntd.0000749.t003
Figure 1. Knowledge of participants about the purpose of a vaccine, assessed before and after viewing the educational video.
doi:10.1371/journal.pntd.0000749.g001
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using the 5-point Likert scale were combined as shown in
Figure 4. However, for both of these measures, the attitudes of
the study participants were somewhat less favorable towards
participating in future vaccine trials after viewing the informa-
tional video, even if these differences weren’t statistically
significant.
Even before the educational intervention took place, more than
95% of the participants interviewed already expressed a favorable
attitude toward the planned vaccine study, displayed confidence in
the work of the researchers and expressed interest in learning more
about hookworm and the experimental hookworm vaccine
(Table 5). In fact, 100% of respondents agreed that the
researchers are doing good work in their community, a percentage
that remained unchanged after viewing the film. After the
educational intervention, although no significant changes were
recorded in the attitudes and feelings regarding aspects of the
hookworm vaccine project, there were reductions in the number of
individuals who were interested in participating in a future vaccine
trial (95.8% before compared to 88.9% after) and in those who
said that their family would approve of their participation in a
vaccine trial (86.1% before compared to 80.1% after).
Closely related to these attitudes was the initial perception that
participating in a vaccine study would result in focused attention
on and treatment of health problems of study participants (95.8%),
an aspect that certainly implies improvement of the health and the
quality of life of each participating individual and indeed, even of
others in the community (91.7%) (Table 5).
Regarding the attitudes and feelings expressed by those
surveyed toward the researchers and the hookworm vaccine
project, it is important to note that the proportion of people
expressing the opinion that being a volunteer in a research study
may complicate daily activities or prove inconvenient increased
slightly after viewing the video: 15.3% and 23.6% held these views
prior to watching the film compared to 23.6% and 27.8% after
(p=0.2 and 0.07, respectively). Furthermore, the percentage of
participants who expressed fear of becoming ill or experiencing an
adverse event also increased significantly, from 29.2% to 51.4%,
respectively (p,0.01).
Discussion
Our study has demonstrated that despite conducting research in a
rural, resource-limited population that has limited access to routine
health care and education, specially-designed educational activities
can significantly improve understanding and therefore the likelihood
of obtaining truly informed consent for clinical research. The observed
changes in the knowledge and perceptions of the research
participants about hookworm infection and the experimental
hookwormvaccine clearly demonstrate that the targeted educational
Figure 2. Knowledge of participants about the possible adverse effects associated with vaccination, assessed before and after the
educational video.
doi:10.1371/journal.pntd.0000749.g002
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subjects acquired knowledge pertinent to the planned research.
Importantly, the increase in knowledge appeared to be sustained, as
the post-video questionnaire was conducted two months following
the viewing of the film and not immediately afterward.
The conceptual evolution following an educational intervention
can be attributed to the non-cognitive educational methodology
that was utilized. The video that was developed and evaluated as
part of this study relied on the use of analogies – for example,
comparing the production of a new vaccine to the making of a
local sweet – to convey new scientific concepts related to
hookworm and research. The analogy is a comparison based on
similarities between the structures of two different fields of
knowledge [27]. Reasoning through analogy is, therefore, a
subjective internal process that is effectuated by the interaction
between two mental fields. The results of the questionnaire
demonstrate that this pedagogical methodology is effective in the
population that was studied.
The educational approach chosen for this study differs from
conventional educational methods, in that it considers the lifestyle
of people, their ideas, beliefs and values, and the specific cultural
context. This leads to enhanced self-esteem, increased community
participation, thus promoting the values of citizenship [28]. As
outlined by Rice and Candeias, the traditional educational model
in which information is simply provided to and individual or
community has only temporary effects in terms of behavior change
[29]. When the educational stimulus ceases, so too are its effects.
The main criticism of the traditional cognitive approach is that it
does not take into consideration the psychosocial and cultural
determinants of health behaviors [30].
Figure 3. Perceptions of the participants about the role of the FIOCRUZ researchers in their community, assessed before and after
the educational video.
doi:10.1371/journal.pntd.0000749.g003
Table 4. Impact of the educational video on attitudes and perceptions about the research team and participation in future vaccine
trials.
Mean Difference (95% CI) P*
Pre-video Post-video
Attitudes and feelings about the researchers
and participating in a vaccine trial
1
0.86 0.83 20.03 (20.003–0.06) 0.07
*Paired Student’s t-test.
1Combination of questions #21–23, #27–29 and #31 from questionnaire.
doi:10.1371/journal.pntd.0000749.t004
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Gerais where schistosomiasis is endemic, different health educa-
tion approaches were assessed regarding their effectiveness in
increasing the knowledge of schoolchildren with respect to the
transmission and prevention of this parasitic disease [31]. This
study demonstrated that in a group of schoolchildren whose
education was based upon a model using analogies or social
representations, levels of knowledge about schistosomiasis in-
creased significantly, compared to those in which a cognitive
model based on the simple presentation of information, or a
control group that received no specific information about the
disease.
Regarding the specific changes in knowledge that were observed
in the current study after the educational intervention, an
increased appreciation of the illness caused by hookworm was
observed, such that after watching the film, it was identified as an
important affliction in the study area due to its endemnicity and its
effect on people’s lives. The understanding that hookworm
infection is not a major health problem because it can be easily
treated with anthelminthic medications was reduced following the
film, serving as evidence of an improved understanding of the re-
infection process wherein individuals are continuously at risk of
infection despite anthelminthic treatment due to the environment
in which they live.
In analyzing the attitudes and perceptions of the participants, it
appears that there were no significant changes in the subjects’
notions in relation to the researcher and the benefits of
participating in clinical trials. Capturing the participants’ perspec-
tive before and after the educational intervention, no change was
observed. Initially, an overall favorable opinion toward the
researchers and the project was observed, with a full 100%
agreeing that the investigators are doing good work in their
community. This good-will and trust towards the researchers
remained unchanged after viewing the educational film, and it
translated into a high level of interest in participating in future
vaccine trials, although this willingness decreased slightly after
viewing the film, perhaps as a result of an increased understanding
of the risks involved, as discussed below.
According to the vast majority of the individuals who were
studied, participating in a vaccine trial might not only benefit
themselves but also bring benefit to others who are not
participants, resulting in betterment of the community as a whole.
Surprisingly, although some participants acknowledged that
participating in a vaccine trial might interfere with their daily
activities, the majority of those interviewed said that it would not
be inconvenient to them. The time commitment involved, which
for these individuals whose livelihoods depend on long hours of
hard manual labor, could be significant but would apparently be
outweighed by the perceived potential benefits of participation
such as improvement of their own health, greater attention to
treatment of health problems, and potential identification of health
problems that are otherwise unrelated to the study or vaccination
with an experimental product.
A broad increase in understanding of the work being conducted
by the research team after viewing the educational film was
observed among those surveyed, although the idea that the
project’s purpose is to treat illness and take care of people’s health
– instead of to conduct research – remained prevalent despite
having viewed the video. Regarding this specific point, it is
important to highlight that understanding the research process is a
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Figure 4. Comparison of responses to questions about the attitudes and perceptions towards the researchers and participation in
vaccine clinical trials, both before and after the educational video. Unfavorable perceptions or attitudes were assigned a value of zero
whereas favorable ones were assigned a value of one. Upper and lower limits of the boxes represent the interquartile ranges.
doi:10.1371/journal.pntd.0000749.g004
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communities in advance of conducting clinical trials and beginning
the individual informed consent process, especially in resource-
limited communities with low levels of literacy and limited access
to routine health care [32].
Since the Na-ASP-2 Hookworm Vaccine is an experimental
vaccine, individuals participating in the planned study of this
investigational product could potentially experience adverse
reactions of variable degrees of severity, although in the first
clinical trial of this vaccine administered to healthy, hookworm-
naı ¨ve volunteers living in the United States, observed reactions
consisted mostly of mild to moderate intensity injection site
reactions such as pain, swelling and erythema [33]. After viewing
the film in which the potential risks of participating in the
proposed vaccine trial were described, an increase in apprehension
related to participation was observed. This should not necessarily
be seen as a negative outcome of the educational video, as it may
in fact reflect a superior understanding of the risks involved when
participating as a volunteer in a clinical vaccine trial – something
that should be welcomed. Even though the educational interven-
tion may have resulted in fewer people who would be willing to
participate (88.9% after watching the video compared to 95.8%
before), if those individuals who remained interested in volunteer-
ing were better informed, the intervention was successful.
In contrast to an increased appreciation of the risks of
participation in a vaccine trial, no significant changes were
observed after the educational intervention in relation to the
perceived benefits that might come from participating in the
research. Among the perceived benefits of participating in a
vaccine trial were improvements in health, treatment of illness,
and a better quality of life.
As demonstrated by our findings, the educational intervention
utilized in this study was not uniformly successful. In several
instances, erroneous perceptions of the study participants – such as
the belief that the purpose of a vaccine is to treat disease, or that
the role of the research is to take care of the health problems of the
population – persisted in a significant proportion of those
interviewed even after viewing the educational video. Obviously,
although these misconceptions were reduced by the use of the
educational video, further work remains to better inform potential
research participants of the nature of research and the purpose of
interventions that might be tested in future research trials. As with
any ongoing research project, obtaining informed consent from
volunteers is an on-going process in which individuals are
continuously engaged in educational activities.
In summary, not only is it important to assess the current level
of understanding of potential vaccine trial participants prior to
conducting clinical studies, it is also useful to design specially-
tailored educational interventions to develop a more informed
community that is able and willing to participate in such research.
This process should be continuous, with frequent re-assessment of
the understanding of individuals that results in revision of the
educational materials. It is the ethical imperative of the
investigators and research team to ensure that potential study
Table 5. Participants’ responses to questions about their attitudes and perceptions about aspects of the hookworm vaccine
project, before and after viewing the educational video.
Responses (%)
Pre-video Post-video
Question Agree
Don’t
Agree
Don’t
Know Agree
Don’t
Agree
Don’t
Know
Are you interested in participating in a hookworm vaccine study? 95.8 4.2 - 88.9 11.1 -
Would your family approve of your participation in a hookworm vaccine study? 86.1 13.9 - 80.1 19.9 -
Do you think that a hookworm vaccine study will help other people? 91.7 8.3 - 88.9 11.1 -
Are you interested in learning about hookworm and the vaccine? 97.2 2.8 - 100 0 -
Are the researchers doing good work in your community? 100 0 - 100 0 -
Do you trust the researchers working in your community? 97.2 2.8 - 95.8 4.0 -
Would you allow a vaccine to be tested on you if it is a new vaccine that
has never been given to people before?
63.9 33.3 2.8 73.6 26.4 0.0
Does being a trial volunteer interfere with daily activities? 15.3 81.9 2.8 23.6 72.2 4.2
Are you scared of becoming sick if vaccinated? 29.2 70.8 0 51.4* 47.2 1.4
Could a hookworm vaccine help others? 86.1 8.3 5.6 93.1 1.4 5.6
Does being a vaccine trial volunteer improve your own health? 94.4 5.6 0 93.1 0 6.9
Will you receive attention and treatment for health problems if you
participate in a vaccine trial?
95.8 2.8 1.4 93.1 0 6.9
Will you learn more about hookworm and health research if you participate
in a vaccine study?
98.6 0 1.4 98.6 0 1.4
Will your family be proud of you if you participate in a vaccine trial? 86.1 9.7 4.2 72.3 19.4 8.3
Will you benefit from a vaccine trial? 93.0 4.2 2.8 84.7 11.1 4.2
Will participating in a vaccine trial be inconvenient for you? 23.6 70.8 5.6 27.8 66.7 5.6
Could the health researchers find a health problem you didn’t know you had? 95.8 2.8 1.4 91.6 4.2 4.2
If you participate in a study, will information about you be kept secret? 59.7 31.9 8.2 65.3 23.6 11.1
*p,0.01
doi:10.1371/journal.pntd.0000749.t005
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undertaken. In resource-limited areas such as our study site, this
often requires more than simply reading the informed consent
document, and may include targeted educational activities similar
to the one tested at our study site.
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